NEW YORK, Nov. 4, 2016 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Impax Laboratories Inc. ("Impax" or the "Company") (NASDAQ: IPXL). Such investors are advised to contact Peretz Bronstein or his investor relations analyst Yael Hurwitz at email@example.com or 212-697-6484.
The investigation concerns reports that Impax has unlawfully conspired with other companies to manipulate generic drug prices and that the Company and certain of its officers and/or directors have violated the federal securities laws.
Bloomberg News reported that Impax is being investigated by the Justice Department, along with other companies including Mylan NV, Allergan PLC, Teva Pharmaceutical Industries Ltd, Endo International Plc, Lannett Co., Sun Pharmaceutical Industries Ltd., Mayne Pharma Group Ltd., and Taro Pharmaceutical Industries Ltd. Bloomberg News said that the "antitrust investigation by the Justice Department, begun about two years ago, now spans more than a dozen companies and about two dozen drugs, according to people familiar with the matter. The grand jury probe is examining whether some executives agreed with one another to raise prices, and the first charges could emerge by the end of the year, they said." Following this news, Impax stock dropped $4.00, or 19.51%, to close at $16.50 on November 3, 2016.
If you are aware of any facts relating to this investigation, or purchased shares Impax, you can assist this investigation by visiting the firm's site: http://www.bgandg.com/ipxl. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484 or via email firstname.lastname@example.org. Those who inquire by e-mail are encouraged to include their mailing address, email and telephone number.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | email@example.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/shareholder-alert-bronstein-gewirtz--grossman-llc-announces-investigation-of-impax-laboratories-inc-ipxl-300357787.html
SOURCE Bronstein, Gewirtz & Grossman, LLC